BioSenic and Pluristyx sign term sheet for market

INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty...

Related Keywords

Paris ,France General ,France ,Belgium ,Mont Saint Guibert ,Waals Gewest ,Belgian ,French ,Annie Florence Loyer ,Bert Bouserie ,Neil Hunter Michelle Boxall ,Seitosei Actifin ,Ghislaine Gasparetto ,Mahendra Rao ,Biosenic Pluristyx ,International Media Enquiries ,Ib Communications ,Cell Bank ,Euronext Brussels ,Mesenchymal Stem Cells ,Bone Therapeutics ,Implant Therapeutics ,Implant Therapeutic Induced Pluripotent Stem Cell ,Chief Executive Officer ,Vice President ,Arsenic Trioxide ,Host Disease ,Systemic Sclerosis ,Louvain La Neuve Science Park ,Mesenchymal Stromal Cells ,Graft Versus Host Disease ,Systemic Lupus ,Chief Executive ,Belgian Media ,Investor Enquiries ,French Media Enquiries ,French Investor Enquiries ,Brussels Stock Exchange Bios ,Biosenic ,